Results

Total Results: 44 records

Showing results for "heart failure".
Users also searched for: quality improvement

1. Apr-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
   January 01, 2017 - CVD can include CHF in some interpretations and statins are not as effective at treating heart failure

2. CDS Connect Patient and Caregiver Partnering Panel - Lessons Learned (pdf file)
   cds.ahrq.gov/sites/default/files/Lessons%20Learned%20Summary%20Sheet%20CDS%20Connect%20Patient%20Partnering%20Panel%202021.pdf
   April 15, 2022 - CDS Connect Patient and Caregiver Partnering Panel - Lessons Learned CDS Connect Patient and Caregiver Partnering Panel We aspire to inspire CDS developers to take one more step to engage and partner with patients and caregivers What is patient and caregiver partnering? Patient partnering, patient engagement, a…

3. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
   February 01, 2018 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk Implementation Guide CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10- Year ASCVD Risk Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Hu…

4. 2022 Intervention Content T2Dm Counseling (xls file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1066/2022_Intervention_Content_T2DM_Counseling.xlsx
   January 01, 2022 - Example Intervention Text Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 2, Counseling General Information The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes: Part 2, Counseling artifact. Implem…

5. 2023 Intervention Content T2Dm Part Two Counseling (xls file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_Intervention_Content_T2DM_Part_Two_Counseling.xlsx
   January 01, 2023 - Example Intervention Text Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 2, Counseling General Information The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes: Part 2, Counseling artifact. Implem…

6. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
   January 01, 2024 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.17 The FHIR Condition clinicalStatus must be “active,” “relapse,” or “recurrence” to ensure

7. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Sept_08.pdf
   February 01, 2018 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk Implementation Guide CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10- Year ASCVD Risk Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Hu…

8. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
   January 01, 2023 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.17 The Clinical Status must be “active,” “relapse,” or “recurrence” to ensure that the condition

9. April 2022 CDS Connect Work Group Call (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Presentation.pdf
   January 01, 2022 - April 2022 CDS Connect Work Group Call April 2022 CDS Connect Work Group Call Agenda Schedule Topic 3:00 – 3:02 Roll Call, Michelle Lenox (MITRE) 3:02 – 3:05 Review of the Agenda, Maria Michaels (CDC) 3:05 - 3:35 Roundtable and Discussion on Partnering Experience: Amy Price (Stanford); Danny van Leeuwen (Heal…

10. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.21 The FHIR Condition clinicalStatus must be “active,” “relapse,” or “recurrence” to ensure

11. Feb-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - there is a fair amount of overlap in indications between hypertension and other conditions, such as heart … failure. · Using diagnoses documented on the problem list alone may compromise sensitivity, as problem

12. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.17 The clinicalStatus must be “active” or “relapse” to ensure that the condition is relevant

13. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.20 The FHIR Condition clinicalStatus must be “active,” “relapse,” or “recurrence” to ensure

14. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
    September 01, 2022 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.16 The Clinical Status must be “active,” “relapse,” or “recurrence” to ensure that the condition

15. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk 1 Implementation Guide CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 …

16. Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
    September 01, 2019 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.21 The clinicalStatus must be “active” or “relapse” to ensure that the condition is relevant

17. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
    April 01, 2021 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.17 The Clinical Status must be “active,” “relapse,” or “recurrence” to ensure that the condition

18. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/508_2022_CDS_Connect_IG_Statin_CVD_Patient_Facing_final.pdf
    January 01, 2022 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.

19. Statin Use for the Primary Prevention of CVD in Adults: Patient-facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final_1.pdf
    April 01, 2021 - nephropathy, peripheral vascular disease, stroke, coronary artery disease, and systolic and diastolic heart … failure.21 The FHIR Condition clinicalStatus must be “active,” “relapse,” or “recurrence” to ensure

20. 2024 Intervention Content Prediabetes And Type 2 Diabetes Part One Screening (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
    January 01, 2024 - Example Intervention Text Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening General Information The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact. Imple…